BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23633236)

  • 1. Improving the accuracy of pancreatobiliary tract cytology with fluorescence in situ hybridization: a molecular test with proven clinical success.
    Kipp BR; Barr Fritcher EG; Pettengill JE; Halling KC; Clayton AC
    Cancer Cytopathol; 2013 Nov; 121(11):610-9. PubMed ID: 23633236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
    Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
    Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine brush cytology and fluorescence in situ hybridization for assessment of pancreatobiliary strictures.
    Smoczynski M; Jablonska A; Matyskiel A; Lakomy J; Dubowik M; Marek I; Biernat W; Limon J
    Gastrointest Endosc; 2012 Jan; 75(1):65-73. PubMed ID: 22078103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of malignant cytologic criteria in pancreatobiliary brushings with corresponding positive fluorescence in situ hybridization results.
    Barr Fritcher EG; Caudill JL; Blue JE; Djuric K; Feipel L; Maritim BK; Ragheb AA; Halling KC; Henry MR; Clayton AC
    Am J Clin Pathol; 2011 Sep; 136(3):442-9. PubMed ID: 21846921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology.
    Barr Fritcher EG; Kipp BR; Halling KC; Clayton AC
    Cytopathology; 2014 Oct; 25(5):288-301. PubMed ID: 25073411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UroVysion Multi-Target Fluorescence in situ Hybridization Assay for the Detection of Malignant Bile Duct Brushing Specimens: A Comparison with Routine Cytology.
    Zhai J
    Acta Cytol; 2018; 62(4):295-301. PubMed ID: 29734171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Moreno Luna LE; Gores GJ
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S15-9. PubMed ID: 17051561
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
    Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
    Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.
    Kipp BR; Stadheim LM; Halling SA; Pochron NL; Harmsen S; Nagorney DM; Sebo TJ; Therneau TM; Gores GJ; de Groen PC; Baron TH; Levy MJ; Halling KC; Roberts LR
    Am J Gastroenterol; 2004 Sep; 99(9):1675-81. PubMed ID: 15330900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and UroVysion™ fluorescent in situ hybridization.
    Huddleston BJ; Lamb RD; Gopez EV; Adler DG; Collins BT
    Diagn Cytopathol; 2012 Apr; 40(4):337-41. PubMed ID: 22431323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
    Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
    von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
    Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
    Liew ZH; Loh TJ; Lim TKH; Lim TH; Khor CJL; Mesenas SJ; Kong CSC; Ong WC; Tan DMY
    J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond cytomorphology: expanding the diagnostic potential for biliary cytology.
    Chadwick BE
    Diagn Cytopathol; 2012 Jun; 40(6):536-41. PubMed ID: 22619128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
    Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
    Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted multiprobe fluorescence in situ hybridization analysis for elucidation of inconclusive pancreatobiliary cytology.
    Vlajnic T; Somaini G; Savic S; Barascud A; Grilli B; Herzog M; Obermann EC; Holmes BJ; Ali SZ; Degen L; Bubendorf L
    Cancer Cytopathol; 2014 Aug; 122(8):627-34. PubMed ID: 24753508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures.
    Moreno Luna LE; Kipp B; Halling KC; Sebo TJ; Kremers WK; Roberts LR; Barr Fritcher EG; Levy MJ; Gores GJ
    Gastroenterology; 2006 Oct; 131(4):1064-72. PubMed ID: 17030177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.